Digging Deep into the Genome: What Genetic Testing Can (and Can’t) Tell Us about Ovarian Cancer

Expert faculty for this 30-minute webinar will include a pathologist and a gynecologic oncologist. Faculty will summarize the latest guidelines on genes that should be tested in ovarian cancer and the appropriate identification of patients who should receive testing.
Category
- Oncology
Format
- On-Demand
Credits
- AMA PRA Category 1 Credit™
- Participation
Appraising Current Safety and Efficacy Data for PARP Inhibitors in Ovarian Cancer: Best Practices in Treatment and Adverse Event Management

Expert faculty for this 30-minute webinar will include a gynecologic oncologist and a nurse.
Category
- Oncology
Format
- On-Demand
Credits
- AMA PRA Category 1 Credit™
- Participation
Recognizing and Addressing the Elephant in the Room: Multidisciplinary Strategies to Mitigate Disparities in Ovarian Cancer Patients

Expert faculty for this 30-minute webinar will include perspectives from a patient, a medical oncologist, and an oncology nurse.
Category
- Oncology
Format
- On-Demand
Credits
- AMA PRA Category 1 Credit™
- Participation
2022 EGFR+ Lung Cancer Rapid Recap: The Evolving State of the Science in EGFR+ NSCLC—A Closer Look at the Paradigm-Shifting Synergy of Safety, Efficacy, and Equitable Access

This Rapid Recap will provide a responsive, timely, and incisive overview of data presented at the 2022 Clinical Oncology Annual Meeting, and offer expert insights into the shifting management landscape for metastatic EGFR+ NSCLC.
Category
- Oncology
Format
- Podcasts
Credits
- ACPE Pharmacy
- AMA PRA Category 1 Credit™
- ANCC
- ICPE
- Participation
Breaking the Cycle in Cardiorenal Anemia Syndrome: The Practice-changing Role of IV Iron at the CKD–Heart Failure Interface

All clinicians managing patients with non-dialysis-dependent chronic kidney disease or heart failure must be aware of the deleterious impacts of concomitant anemia and the established, emerging, and practice-changing role of intravenous (IV) iron therapies.
Category
- Cardiology
Format
- On-Demand
Credits
- AMA PRA Category 1 Credit™
- Participation
Evolving Treatment Paradigms for Bladder Cancer: Expert Perspectives on the Latest Data

Join key thought leaders in the world of bladder cancer – Drs.
Category
- Hematology
- Oncology
Format
- On-Demand
Credits
- AMA PRA Category 1 Credit™
- Participation
Breaking the Cycle in Cardiorenal Anemia Syndrome: The Practice-changing Role of IV Iron at the CKD–Heart Failure Interface

All clinicians managing patients with non-dialysis-dependent chronic kidney disease or heart failure must be aware of the deleterious impacts of concomitant anemia and the established, emerging, and practice-changing role of intravenous (IV) iron therapies.
Category
- Cardiology
Format
- Podcasts
Credits
- AMA PRA Category 1 Credit™
- Participation
Navigating the Evolving Bladder Cancer Landscape: The Nurse’s Role Improving Patient Outcomes

Join our expert Nursing faculty as they review immune checkpoint inhibitor (ICI) data across bladder cancer treatment, from NMIBC to MIBC to locally advanced/metastatic disease.
Category
- Oncology
Format
- Chapter Meetings
- Grand Rounds
Credits
- ANCC
- Participation
CEConcepts Enduring: Addressing Unmet Needs in Advanced Endometrial Cancer: The Latest Advances for the Oncology Nurse

Strategically designed to foster an understanding of both the disease state complexity and far-reaching disparity intrinsic to endometrial cancer, this educational session will begin with an appraisal of the utility and importance of biomarker testing in advanced endome
Category
- Oncology
Format
- Chapter Meetings
- Grand Rounds
Credits
- ANCC
- Participation
Optimizing Cancer-related Anemia Outcomes in the Community Setting: Interprofessional Approaches and Evidence-supported Strategies for Improving Care with Intravenous Iron

Listen on CEConversations
Category
- Hematology
- Oncology
Format
- Chapter Meetings
- Podcasts
- Grand Rounds
Credits
- ACPE Pharmacy
- AMA PRA Category 1 Credit™
- ANCC
- ICPE
- Participation